Skip to main content
Top
Published in: Pituitary 1/2007

01-03-2007

Gene expression profiling in human null cell pituitary adenoma tissue

Authors: Ji Hu, Huaidong Song, Xuanchun Wang, Ye Shen, Fengling Chen, Yu Liu, Shiqi Li, Yongfei Wang, Xuefei Shou, Yulin Zhang, Renming Hu

Published in: Pituitary | Issue 1/2007

Login to get access

Abstract

It is estimated that up to one in five individuals develops pituitary gland tumors, despite the common occurrence of these tumors, the pathogenetic mechanisms underlying their development mainly remain unknown. We studied the gene expression in null cell adenomas compared with normal pituitary by expressed sequence tags (EST) sequencing and cDNA microarray on large scale. Both approaches of EST sequencing and microarray analysis showed that 17 genes were differentially expressed in human null cell pituitary adenoma tissues, among which 14 genes were overexpressed and three genes were underpressed. Five of the genes with potential oncogenic significance by RT-real time quantitative PCR. Synaptotagmin (SYT) are integral membrane proteins of synaptic vesicles considered to serve as Ca2+ sensors in the process of vesicular trafficking and exocytosis. Calcium binding to participates in triggering neurotransmitter release at the synapse. In view of our finding that SYT is overexpressed in null cell adenomas, these tumors may be capable of secreting some unknown hormones or peptides. ATP5B and MDH1 were involved in the energy metabolism, whose overexpression in null cell adenomas provide us with a new perspective of exploring the oncogenesis of these tumors. All of these data may contribute to the understanding of null cell adenoma formation and development.
Literature
1.
go back to reference Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603–1618PubMedCrossRef Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603–1618PubMedCrossRef
2.
go back to reference Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL, Fu G, Zhang QH, Gu BW, Dai M, Mao YF, Gao GF, Rong R, Ye M, Zhou J, Xu SH, Gu J, Shi JX, Jin WR, Zhang CK, Wu TM, Huang GY, Chen Z, Chen MD, Chen JL (2000) Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci USA 97:9543–9548PubMedCrossRef Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL, Fu G, Zhang QH, Gu BW, Dai M, Mao YF, Gao GF, Rong R, Ye M, Zhou J, Xu SH, Gu J, Shi JX, Jin WR, Zhang CK, Wu TM, Huang GY, Chen Z, Chen MD, Chen JL (2000) Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci USA 97:9543–9548PubMedCrossRef
3.
go back to reference Wang XC, Xu SY, Wu XY, Song HD, Mao YF, Fan HY, Yu F, Mou B, Gu YY, Xu LQ, Zhou XO, Chen Z, Chen JL, Hu RM (2004) Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs. Endocr Relat Cancer 11:295–303PubMedCrossRef Wang XC, Xu SY, Wu XY, Song HD, Mao YF, Fan HY, Yu F, Mou B, Gu YY, Xu LQ, Zhou XO, Chen Z, Chen JL, Hu RM (2004) Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs. Endocr Relat Cancer 11:295–303PubMedCrossRef
4.
go back to reference Kovacs K, Horvath E, Vidal S (2001) Classification of pituitary adenomas. J Neuro-Oncol 54:121–127CrossRef Kovacs K, Horvath E, Vidal S (2001) Classification of pituitary adenomas. J Neuro-Oncol 54:121–127CrossRef
5.
go back to reference Poskanzer KE, Marek KW, Sweeney ST, Davis GW (2003) Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo. Nature 426:559–563PubMedCrossRef Poskanzer KE, Marek KW, Sweeney ST, Davis GW (2003) Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo. Nature 426:559–563PubMedCrossRef
6.
go back to reference Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C, Sudhof TC (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature 410:41–49PubMedCrossRef Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C, Sudhof TC (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature 410:41–49PubMedCrossRef
7.
go back to reference Neckelmann N, Warner CK, Chung A, Kudoh J, Minoshima S, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Liu JD (1989) The human ATP synthase beta subunit gene: sequence analysis, chromosome assignment, and differential expression. Genomics 5:829–843PubMedCrossRef Neckelmann N, Warner CK, Chung A, Kudoh J, Minoshima S, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Liu JD (1989) The human ATP synthase beta subunit gene: sequence analysis, chromosome assignment, and differential expression. Genomics 5:829–843PubMedCrossRef
8.
go back to reference Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ (1994) A novel ligand in lymphocyte-mediated cytotoxicity: expression of the/3 subunit of H+ transporting ATP synthase on the surface of tumor cell lines. J Exp Med 180:273–281PubMedCrossRef Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ (1994) A novel ligand in lymphocyte-mediated cytotoxicity: expression of the/3 subunit of H+ transporting ATP synthase on the surface of tumor cell lines. J Exp Med 180:273–281PubMedCrossRef
9.
go back to reference Tanaka T, Inazawa J, Nakamura Y (1996) Molecular cloning and mapping of a human cDNA for cytosolic malate dehydrogenase (MDH1). Genomics 32:128–130PubMedCrossRef Tanaka T, Inazawa J, Nakamura Y (1996) Molecular cloning and mapping of a human cDNA for cytosolic malate dehydrogenase (MDH1). Genomics 32:128–130PubMedCrossRef
Metadata
Title
Gene expression profiling in human null cell pituitary adenoma tissue
Authors
Ji Hu
Huaidong Song
Xuanchun Wang
Ye Shen
Fengling Chen
Yu Liu
Shiqi Li
Yongfei Wang
Xuefei Shou
Yulin Zhang
Renming Hu
Publication date
01-03-2007
Published in
Pituitary / Issue 1/2007
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0008-z

Other articles of this Issue 1/2007

Pituitary 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.